Prioritizing genetic testing in patients with Kallmann syndrome using clinical phenotypes

Area of Science:

• Genetics
• Endocrinology
• Reproductive Medicine

Background:

• Genetic testing for Kallmann syndrome (KS) is complex and costly.
• Leveraging clinical evaluations is crucial for prioritizing genetic screening in KS patients.

Purpose of the Study:

• To identify specific gene mutations linked to reproductive and nonreproductive phenotypes in KS subjects.
• To correlate clinical manifestations with genetic variations in Kallmann syndrome.

Main Methods:

• Studied 219 KS patients: 151 with known gene mutations (RSVs) and 68 without.
• Assessed reproductive and nonreproductive phenotypes in relation to identified genetic variants.
• Compared clinical features across different genetic groups, including KAL1, NELF, CHD7, HS6ST1, FGF8/FGFR1, and PROK2/PROKR2.

Main Results:

• Male KS patients with KAL1 mutations showed the most severe reproductive phenotype (severely reduced testicular volumes).
• Synkinesia was more common in patients with KAL1 mutations.
• Dental agenesis and digital bone abnormalities were linked to FGF8/FGFR1 pathway mutations.
• Hearing loss was associated with CHD7 mutations.

Conclusions:

• Specific clinical features can predict genetic causes of KS.
• Synkinesia (KAL1), dental agenesis (FGF8/FGFR1), digital abnormalities (FGF8/FGFR1), and hearing loss (CHD7) are valuable for prioritizing genetic screening in KS.